Advertisement

U.S. markets open in 4 hours 29 minutes

S&P Futures
4,158.25
+11.50(+0.28%)
Dow Futures
32,822.00
+65.00(+0.20%)
Nasdaq Futures
13,292.00
+63.25(+0.48%)
Russell 2000 Futures
1,925.60
+3.80(+0.20%)
Crude Oil
88.33
-0.68(-0.76%)
Gold
1,789.30
-1.90(-0.11%)

Advertisement

VRTX Sep 2022 125.000 put

OPR - OPR Delayed Price. Currency in USD

Add to watchlist

0.5000

0.0000

(0.00%)

As of 02:36PM EDT. Market open.

Advertisement

Motley Fool
2 Top Biotech Stocks Defying the Bear Market
Vertex Pharmaceuticals' shares have soared 24% year to date despite the macroeconomic headwinds in its way. The biotech owes that in part to its dominance in the market for drugs that treat the underlying causes of cystic fibrosis (CF), an area in which Vertex is the only game in town. Revenue and earnings continue to grow for Vertex thanks to its CF franchise.
Investor's Business Daily
Vertex Makes Bullish Move On Earnings, Leading 5 Stocks To Watch
Vertex Pharmaceuticals made a bullish move on earnings amid a confirmed market rally, leading five stocks to watch this week.
Investor's Business Daily
Vertex Raises 2022 Outlook As Powerhouse Trikafta Drives Quarterly Beat
Vertex Pharmaceuticals said its triple-regimen in cystic fibrosis is gaining new users abroad. VRTX stock jumped Friday.